| Literature DB >> 28348517 |
Beier Bao1, Yingzi He2, Dongmei Tang2, Wenyan Li2, Huawei Li3.
Abstract
The H3K27 demethylases are involved in a variety of biological processes, including cell differentiation, proliferation, and cell death by regulating transcriptional activity. However, the function of H3K27 demethylation in the field of hearing research is poorly understood. Here, we investigated the role of H3K27me3 histone demethylase activity in hair cell regeneration using an in vivo animal model. Our data showed that pharmacologic inhibition of H3K27 demethylase activity with the specific small-molecule inhibitor GSK-J4 decreased the number of regenerated hair cells in response to neomycin damage. Furthermore, inhibition of H3K27me3 histone demethylase activity dramatically suppressed cell proliferation and activated caspase-3 levels in the regenerating neuromasts of the zebrafish lateral line. GSK-J4 administration also increased the expression of p21 and p27 in neuromast cells and inhibited the ERK signaling pathway. Collectively, our findings indicate that H3K27me3 demethylation is a key epigenetic regulator in the process of hair cell regeneration in zebrafish and suggest that H3K27me3 histone demethylase activity might be a novel therapeutic target for the treatment of hearing loss.Entities:
Keywords: GSK-J4; H3K27 demethylation; hair cell; regeneration; zebrafish
Year: 2017 PMID: 28348517 PMCID: PMC5346882 DOI: 10.3389/fnmol.2017.00051
Source DB: PubMed Journal: Front Mol Neurosci ISSN: 1662-5099 Impact factor: 5.639
Figure 1GSK-J4 impaired hair cell regeneration after neomycin damage. (A–D) GSK-J4 reduced the numbers of GFP-positive (green) and FM1-43FX-positive (red) hair cells compared with DMSO-treated controls. Scale bars = 10 μm. (E,F) Quantitative analysis of the number of GFP-positive (E) or FM1-43FX-positive (F) hair cells per neuromast (NM) at different time points in DMSO-treated control and GSK-J4-treated larvae. In the 24-h group, n = 40 neuromasts (20 larvae) per group; in the 48-h group, n = 28 neuromasts (14 larvae) per group. ***p < 0.0001. Bars are mean ± sem. [24-h group: One-way ANOVA; GFP-positive cells: F(2, 117) = 96.94; FM1-43FX-positive cells: F(2, 117) = 114. 48-h group: One-way ANOVA; GFP-positive cells: F(2, 81) = 88.96; FM1-43FX-positive cells: F(2, 81) = 93.85].
Figure 2GSK-J4 reduced proliferation in regenerating neuromast cells. (A–D) 5 dpf larvae were treated with 400 μM neomycin for 1 h followed by GSK-J4 exposure for 24 or 48 h in the presence of BrdU. GSK-J4 significantly reduced the numbers of Sox2-positive (red) and BrdU-positive (white) replicating cells. Scale bars = 10 μm. (E,F) Quantification of Sox2-positive and BrdU-positive cells per neuromast (NM) in DMSO-treated control larvae and 10 μM GSK-J4-treated larvae at 24 or 48 h following neomycin damage. In the 24-h group, n = 30 neuromasts of DMSO-treated control larvae (15 larvae) and n = 24 neuromasts of 10 μM GSK-J4-treated larvae (12 larvae); in the 48-h group, n = 36 neuromastsof DMSO-treated control larvae (18 larvae) and n = 24 neuromasts of 10 μM GSK-J4-treated larvae (12 larvae). ***p < 0.0001. (24-h group: Sox2-positive cells: unpaired t-test, two-tailed, t = 7.412, df = 52; BrdU-positive cells: unpaired t-test, two-tailed, t = 13.86, df = 52. 48-h group: Sox2-positive cells: unpaired t-test, two-tailed, t = 7.463, df = 58; BrdU-positive cells: unpaired t-test, two-tailed, t = 15.6, df = 58). Bars are mean ± sem. (G,H) Quantitative analysis of the proportion of BrdU-positive hair cells (G) or BrdU-positive supporting cells (H) in control and GSK-J4-treated larvae at 24 or 48 h after neomycin damage. In the 24-h group, n = 30 neuromasts of DMSO-treated control larvae (15 larvae) and n = 24 neuromasts of 10 μM GSK-J4-treated larvae (12 larvae); in the 48-h group, n = 36 neuromasts of DMSO-treated control larvae (18 larvae) and n = 24 neuromasts of 10 μM GSK-J4-treated larvae (12 larvae). ***p < 0.0001. (24-h group: BrdU-positive HCs: unpaired t-test, two-tailed, t = 5.309, df = 52; BrdU-positive SCs: unpaired t-test, two-tailed, t = 6.294, df = 52. 48-h group: BrdU-positive HCs: unpaired t-test, two-tailed, t = 7.279, df = 58; BrdU-positive SCs: unpaired t-test, two-tailed, t = 9.546, df = 58). Bars are mean ± sem. (I) Localization of the p21 and p27 genes by whole-mount in situ hybridization in GSK-J4-treated and DMSO-treated control larvae. GSK-J4 treatment significantly increased the expression of p21 and p27 in regenerating neuromasts at 12 hpt. (n = 20–26 neuromasts per group). Results from single representative neuromasts are shown.
Figure 3GSK-J4 induced apoptosis in the regenerating neuromasts. (A,B) Cleaved caspase-3 staining in the neuromasts from a DMSO-treated control larva (A) and a GSK-J4-treated larva (B) at 48 h after neomycin damage. Scale bar = 10 μm. (C) Quantitative analysis of the number of cleaved caspase-3-labeled cells in DMSO-treated control and GSK-J4-treated larvae. n = 24 neuromasts (12 larvae) per group. **p < 0.001 (unpaired t-test, two-tailed, t = 3.368, df = 44, p = 0.0016). (D) Cleaved-caspase-3-specific western blot analysis of whole larvae treated with either DMSO (neo Con; n = 6 larvae) or 10 μM GSK-J4 (neo GSK-J4; n = 6 larvae) for 48 h. The relative expressions of cleaved-caspase-3/β-actin were calculated. **p < 0.001.
Figure 4GSK-J4 increased the levels of H3K27me3. (A,B) Immunohistochemistry results showing H3K27me3 expression in neuromasts of DMSO-treated control (Con) larvae (n = 5 larvae) and of 10 μM GSK-J4-treated larvae (n = 6 larvae) for 48 h. Scale bar = 10 μm. (C) Western blot analysis was performed to evaluate the expressions of H3K27me3 and β-actin in whole larvae that were treated with either DMSO (neo Con; n = 6 larvae) or GSK-J4 (neo GSK-J4; n = 6 larvae) for 48 h. *p < 0.05.
Figure 5GSK-J4 decreased phosphorylation of ERK1/2 (p-ERK1/2) in zebrafish larvae. Western blot analysis was performed to detect the expressions of p-ERK1/2 and ERK1/2 in DMSO-treated control larvae (neo Con; n = 6 larvae) and GSK-J4-treated larvae (neo GSK-J4; n = 6 larvae). ***p < 0.0001.